Comparison of 5‐Fluorouracil/Leucovorin and Capecitabine as Adjuvant Therapies in Biliary Tract Cancer
In patients with curatively resected BTC, capecitabine demonstrated superior efficacy in prolonging overall survival, whereas FL had a more favorable safety profile with fewer adverse events.
Authors
- Junyeol Kim (ORCID: https://orcid.org/0009-0008-7262-7474)
- Myung Ah. Lee
- Ji Kon Ryu (ORCID: https://orcid.org/0000-0001-8798-0491)
- In Rae Cho (ORCID: https://orcid.org/0000-0001-9874-5526)
- Kwang Yeol Paik
- In Seok Lee (ORCID: https://orcid.org/0000-0002-1127-1522)
- Woo Hyun Paik (ORCID: https://orcid.org/0000-0001-8708-3280)
- Myeong Hwan Lee (ORCID: https://orcid.org/0000-0002-9583-730X)
- Yong Tae Kim (ORCID: https://orcid.org/0000-0003-2996-9969)
- Sang Hyub Lee (ORCID: https://orcid.org/0000-0003-2174-9726)
- Woo Il Kwon
- Young Hoon Choi
- Tae Seung Lee
- Jin‐Young Jang
Institutions
- Seoul National University (KR)
- Samsung Medical Center (KR)
- Seoul National University Hospital (KR)
- Sungkyunkwan University (KR)
- Catholic University of Korea (KR)
Publication Details
- Journal
- Journal of Gastroenterology and Hepatology
- Published
- 2025-07-14
- DOI
- https://doi.org/10.1111/jgh.17044
- Citations
- 1
- Primary Topic
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 2.01